Industry News

BTE Enters Accord with Motorika to Represent and Distribute ReoGo, ReoAmbulator in US

Published on

BTE, based in Hanover Md, has entered an agreement with Mt Laurel, NJ-headquartered Motorika to market and distribute advanced solutions for patients suffering from stroke, spinal cord injury, and traumatic brain injury in the United States of America.
BTE and Motorika’s customer base includes hospitals, clinics, long-term care facilities, and dealers worldwide.
The Motorika ReoGo is described as a three-dimensional robotic-assisted device designed to aid in the rehabilitation of patients affected by stroke and other brain-related injuries. Used to improve control and function in the upper extremities, it is sold worldwide. The ReoGo has been on the market for several years, and is now available for order in the US market exclusively through BTE, according to a media release from BTE.
ReoAmbulator is an innovative gait-training device integrating advanced robotics into body-weight-supported treadmill training. It is engineered as a powerful tool for rehabilitating stroke, spinal cord injury, and traumatic brain injury patients suffering from issues with ambulation, balance, and coordination. ReoAmbulator is now available to the US neurological rehab market through BTE.
“We are very excited to increase our penetration of the US market, complementing BTE’s strong portfolio of rehabilitation products through our new partnership,” commented Gideon Rossman, vice president sales and marketing of Motorika. “Joining Motorika’s leading-edge neuro rehab technology with BTE’s 35 years of expertise in human performance is a perfect match. This synergy is helping us improve the lives of more Americans suffering from stroke and neurological issues, ranging from subacute to chronic – delivering the incredible benefits of interactive, robotic-assisted therapy to help improve function,” adds Thomas P. Rogan, chief executive officer of BTE.
[Source: BTE]